Key statistics
As of last trade, Fibrobiologics Inc (SG0:BER) traded at 2.36, 136.00% above the 52 week low of 1.00 set on Aug 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.36 |
---|---|
High | 2.36 |
Low | 2.34 |
Bid | 2.22 |
Offer | 2.50 |
Previous close | 2.34 |
Average volume | 0.00 |
---|---|
Shares outstanding | 35.16m |
Free float | 26.84m |
P/E (TTM) | -- |
Market cap | 90.71m USD |
EPS (TTM) | -0.939 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 11:12 BST.
More ▼
Announcements
- FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
- FibroBiologics Engages Southern Star Research as CRO in Australia
- FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
- FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
- FibroBiologics Files 2024 Second Quarter Report
- FibroBiologics to Present at JonesTrading Healthcare Summit 2024
- FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
- FibroBiologics Set to Join Russell 2000® Index
- FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
More ▼